Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis

Patrick P Y Chan; Mahtab Farzin; Priya Acharya; Nicholas Viiala; Andrew Gilmore; Harry Crane; Christopher Henderson; Watson Ng; Astrid Williams; Susan J Connor

doi:10.14309/crj.0000000000000978

Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis

ACG Case Rep J. 2023 Feb 10;10(2):e00978. doi: 10.14309/crj.0000000000000978. eCollection 2023 Feb.

Authors

Patrick P Y Chan^{1

2}, Mahtab Farzin^{1

3}, Priya Acharya^{3

4}, Nicholas Viiala¹, Andrew Gilmore^{1

3}, Harry Crane¹, Christopher Henderson^{1

2

3}, Watson Ng^{1

2

5}, Astrid Williams^{1

2

5}, Susan J Connor^{1

2

5}

Affiliations

¹ Department of Gastroenterology and Hepatology, Liverpool Hospital, Liverpool, NSW, Australia.
² South West Sydney Clinical Campus, University of NSW (UNSW) Medicine & Health, University of New South Wales, NSW, Australia.
³ Western Sydney University, Campbelltown, NSW, Australia.
⁴ Department of Gastroenterology, Campbelltown Hospital, Campbelltown, NSW, Australia.
⁵ Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia.

Abstract

Epstein-Barr virus-associated mucocutaneous ulcer is a rare lymphoproliferative disorder that occurs in immunosuppressed states that can develop in the gastrointestinal tract and mimic inflammatory bowel disease or other malignancies. We present the case of a 61-year-old man who presented with concurrent acute severe ulcerative colitis and colonic Epstein-Barr virus-associated mucocutaneous ulcer requiring rituximab therapy and a subtotal colectomy.

Publication types

Case Reports